Tuesday, January 25th – Thursday, January 27th
Digital Event: |
Overview:
Outcome’s Dr. John Armstrong will be providing An Overview of the TGF-β IO Market including:
For more information, please contact jarmstrong@outcomecapital.com |
BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ELIOS Vision, Inc. completed a growth financing round to support its European commercialization. Outcome Capital served as the exclusive strategic and financial advisor to the company. ELIOS’ implant-free, minimally invasive Excimer Laser Trabeculostomy glaucoma procedure is approved […]
Read MoreOutcome Capital Life Science Market Pulse July 2022 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?